OBJECTIVE To study the absorption,distribution,excretion,bioavailability and protein binding of nicotinylsalicylic acid in dog,rabbit and mice.METHODS The HPLC assay was used to determine the nicotinylsalicylic acid concentrations in biological samples.RESULTS The concentration-time curve of nicotinylsalicylic acid in dogs after an ig administration of 100 mg·kg-1 was discribed by a two-compartment open model with the elimination half-life of 0.61 h.The relative bioavailability of nicotinylsalicylic acid in rabbits was 64%.The level of nicotinylsalicylic acid was very low in mice heart,liver,brain and kidney,because it was metabolized to active nicotinic acid and salicylic acid.The protein binding rates of nicotinylsalicylic acid were in the range of 37.3%～57.4%.Nicotinylsalicylic acid at low level,and both of salicylic acid and nicotinic acid at high level were obtained in rabbit urine.CONCLUSION The absorption of nicotinylsalicylic acid is rapid,its half-life is short because it is metabolized to active nicotinic acid and salicylic acid in liver and plasma.The tissue distribution and protein binding is low.Nicotinic acid,salicylic acid and their metabolites are excreted by kidney.
ZHNG Mei;WU Yue;ZHOU Yun;LI Li-yn;YNG Xu-hui;CHEN Wen.
Pharmacokinetics of Nicotinylsalicylic Acid and Its Active Metabolites in vivo[J]. Chinese Pharmaceutical Journal, 2006, 41(04): 299-302
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] LIU H H， WU Y， ZHANG M，et al. Synthesis and lipidemic-modulating effect of nicotinylsalicylic acid[J] .J Shihezi Unive(Natural Science)(石河子大学学报)，2004，22(6)：483-486.
[2] ZHU M H， DING Y S， WU Y，et al. Preventive effect of nicotinyl salicylic acid on experimental atherosclerosis in quails[J] .Chin Pharm Bull(中国药理学通报)，2005，21(9)：1074-1078.
[3] TIAN H， WU Y， ZHANG M，et al. Therapeutic action of nicotinylsalicylic acid on experimental atherosclerosis in quails[J] .Chin J Gerontol(中国老年学杂志)，2005，25(7)：799-801.
[4] DING Y S， YANG G， AN J L.Effect of nicotinylsalicylic acid to model of gastric ulcer， blood sugar and uricacid of rats[J] . J Shihezi University(Natural Science)(石河子大学学报)，2005，23(1)：5-7.
[5] KLIMES J， SOCHOR J， ZAHRADNICEK M，et al. Simultaneous high-performance chromatographic determination of salicylates in whole blood， plasma and isolated erthrcytes[J] .J Chromatogr，1992， 584(2)：221-228.
[6] ZARZYCKI P K， KOWALSKI P. High-performance liquid chromatographic and capillary electrophoretic determination of free nicotinic acid in human plasma and seperation of its metabolites by capillary electrophoresis[J] .J Chromatog，1995， 709(1)： 203-208.
[7] LEVY G. Clinical pharmacokinetics of salicylates：a re-assessment[J] .Br J Clin Pharmcol，1980，10 Suppl 2： 285s-290s.
[8] BESSEGHIR K， MOSIG D. Transport of the organic cation N1-methylnicotinamide by the rabbit proximal tubule and accumulation in the isolated nonperfused tubbule[J] .J Pharmacol Exp Ther，1990，253（2）：444-451.
[9] LI L R， TAN Y L， ZHANG S. Pharmacokinetics and relative bioavailability of shuanghuanglian injection in rabbis by rectal medication[J] .Chin J Clin Pharmacol Ther(中国临床药理学与治疗学)，2002，7(6)：525-528.
[10] YU M， LIU J L， SUN G Z，et al.Relative biovavailability and bioequivalence of Ruxiankang oral liquid[J] .Heilongjiang Med Pharm(黑龙江医药科学)，2002，25 (5)：49-50.
[11] SHIBATA K， KAKEHI H. Niacin catabolism in rodents[J] .J Nutr Sci Viaminol，1990，36（2）：87-98.
